Insights

Global Market Focus AffaMed Therapeutics focuses on developing pharmaceutical products for ophthalmic, neurological, and psychiatric disorders for patients not only in Greater China but also worldwide. This global approach opens up potential sales opportunities in diverse markets.

Experienced Leadership Team The leadership team at AffaMed Therapeutics brings deep industry expertise from leading multinational pharmaceutical companies. Leveraging their extensive experience in clinical development and commercial operations, the company is well-positioned to engage with key stakeholders and drive sales growth.

Innovative Technology Stack Utilizing cutting-edge technologies such as Kubernetes, Docker, and Node.js, AffaMed Therapeutics demonstrates a commitment to innovation in product development. This tech-forward approach can be highlighted to attract tech-savvy clients seeking advanced healthcare solutions.

Strong Financial Backing With a significant funding of $170M and a revenue range of $10M - $50M, AffaMed Therapeutics showcases financial stability and growth potential. This solid financial foundation can instill confidence in potential clients and investors, paving the way for successful sales negotiations.

Competitive Positioning By offering a unique portfolio of pharmaceutical, digital, and surgical products for critical medical needs, AffaMed Therapeutics distinguishes itself from competitors in the biotechnology research industry. This competitive edge can be emphasized to attract clients looking for innovative solutions in the healthcare sector.

AffaMed Therapeutics Tech Stack

AffaMed Therapeutics uses 8 technology products and services including Kubernetes, Docker, Webpack, and more. Explore AffaMed Therapeutics's tech stack below.

  • Kubernetes
    Containerization
  • Docker
    Containerization
  • Webpack
    Miscellaneous
  • JavaScript
    Programming Languages
  • TypeScript
    Programming Languages
  • Android
    Programming Languages
  • Node.js
    Programming Languages
  • HSTS
    Security

Media & News

AffaMed Therapeutics's Email Address Formats

AffaMed Therapeutics uses at least 1 format(s):
AffaMed Therapeutics Email FormatsExamplePercentage
First.Last@affamed.comJohn.Doe@affamed.com
46%
First_Last@affamed.comJohn_Doe@affamed.com
5%
First.Middle@affamed.comJohn.Michael@affamed.com
3%
First.Last@affamed.comJohn.Doe@affamed.com
46%

Frequently Asked Questions

Where is AffaMed Therapeutics's headquarters located?

Minus sign iconPlus sign icon
AffaMed Therapeutics's main headquarters is located at 288 Shimen Yi Road Shanghai, CN. The company has employees across 2 continents, including AsiaNorth America.

What is AffaMed Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
AffaMed Therapeutics's official website is affamed.com and has social profiles on LinkedIn.

How much revenue does AffaMed Therapeutics generate?

Minus sign iconPlus sign icon
As of September 2024, AffaMed Therapeutics's annual revenue reached $15M.

What is AffaMed Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
AffaMed Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AffaMed Therapeutics have currently?

Minus sign iconPlus sign icon
As of September 2024, AffaMed Therapeutics has approximately 51 employees across 2 continents, including AsiaNorth America. Key team members include Chief Regulatory Officer, Global Regulatory Science; Member Of Core Leadership Team: R. Y.Chief Scientific Officer: C. X.Chief Scientific Officer: C. X.. Explore AffaMed Therapeutics's employee directory with LeadIQ.

What industry does AffaMed Therapeutics belong to?

Minus sign iconPlus sign icon
AffaMed Therapeutics operates in the Biotechnology Research industry.

What technology does AffaMed Therapeutics use?

Minus sign iconPlus sign icon
AffaMed Therapeutics's tech stack includes KubernetesDockerWebpackJavaScriptTypeScriptAndroidNode.jsHSTS.

What is AffaMed Therapeutics's email format?

Minus sign iconPlus sign icon
AffaMed Therapeutics's email format typically follows the pattern of . Find more AffaMed Therapeutics email formats with LeadIQ.

How much funding has AffaMed Therapeutics raised to date?

Minus sign iconPlus sign icon
As of September 2024, AffaMed Therapeutics has raised $170M in funding. The last funding round occurred on Mar 30, 2021 for $170M.

When was AffaMed Therapeutics founded?

Minus sign iconPlus sign icon
AffaMed Therapeutics was founded in 2019.
AffaMed Therapeutics

AffaMed Therapeutics

Biotechnology ResearchShanghai, China51-200 Employees

AffaMed Therapeutics is a clinical stage therapeutic company focused on developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmic, neurological and psychiatric disorders for patients in Greater China and around the world. The leadership team of AffaMed Therapeutics has gained deep industry expertise and an extensive track record in high-quality discovery, clinical development, regulatory affairs, manufacturing, commercial operations, and business development at leading multi-national pharmaceutical companies in China and globally.

Section iconCompany Overview

Headquarters
288 Shimen Yi Road Shanghai, CN
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $170M

    AffaMed Therapeutics has raised a total of $170M of funding over 1 rounds. Their latest funding round was raised on Mar 30, 2021 in the amount of $170M.

  • $10M$50M

    AffaMed Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $170M

    AffaMed Therapeutics has raised a total of $170M of funding over 1 rounds. Their latest funding round was raised on Mar 30, 2021 in the amount of $170M.

  • $10M$50M

    AffaMed Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.